STRO-002 - Sutro Biopharma
|
datopotamab deruxtecan (DS-1062a) - Daiichi Sankyo, AstraZeneca
|
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
|
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
|
patritumab deruxtecan (U3-1402) - Daiichi Sankyo
|
MGC018 - MacroGenics, Byondis
|